Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 25, 2011

BD Extends Reagent Supply Contract with Abaxis

  • Abaxis and BD have inked a new 10-year agreement in which Abaxis will supply its Orbos Discrete Lyophilization Process to BD. The deal takes effect immediately and replaces a previous and expiring five-year agreement. Abaxis has been a supplier to BD since 1994. The new contract has an estimated value, based on current demand, of $30 million over the life of the contract.

    Abaxis uses the Orbos Discrete Lyophilization Process to produce dry reagents. The process involves flash-freezing a drop of liquid reagent to form a solid bead and then freeze-drying the bead to remove water. The Orbos beads are stable in dry form and dissolve rapidly in aqueous solutions.

    The Orbos process has applications in products where delivery of active ingredients in a stable, premetered format is desired. It allows the production of a precise amount of active chemical ingredient in the form of a soluble bead, according to Abaxis.

    Abaxis also licenses its Orbos process to bioMerieux, Cepheid, and GE Healthcare. In addition, it has a supply contract with Becton, Dickinson and Company for products using the Orbos process.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Pharmacists and Prescription Drug Misuse Programs

Do you agree that pharmacists should make a greater effort to become more involved with prescription drug-monitoring programs?

More »